ES522086A0 - Procedimiento para la obtencion de lineas de celulas animales y humanas cultivables permanentemente. - Google Patents

Procedimiento para la obtencion de lineas de celulas animales y humanas cultivables permanentemente.

Info

Publication number
ES522086A0
ES522086A0 ES522086A ES522086A ES522086A0 ES 522086 A0 ES522086 A0 ES 522086A0 ES 522086 A ES522086 A ES 522086A ES 522086 A ES522086 A ES 522086A ES 522086 A0 ES522086 A0 ES 522086A0
Authority
ES
Spain
Prior art keywords
animal
procedure
cell lines
human cell
cultivable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES522086A
Other languages
English (en)
Other versions
ES8402346A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES522086A0 publication Critical patent/ES522086A0/es
Publication of ES8402346A1 publication Critical patent/ES8402346A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
ES522086A 1982-05-04 1983-05-04 Procedimiento para la obtencion de lineas de celulas animales y humanas cultivables permanentemente. Expired ES8402346A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3216650 1982-05-04
DE19823245665 DE3245665A1 (de) 1982-05-04 1982-12-09 Verfahren zur herstellung permanenter tierischer und humaner zellinien und deren verwendung

Publications (2)

Publication Number Publication Date
ES522086A0 true ES522086A0 (es) 1984-02-01
ES8402346A1 ES8402346A1 (es) 1984-02-01

Family

ID=25801552

Family Applications (1)

Application Number Title Priority Date Filing Date
ES522086A Expired ES8402346A1 (es) 1982-05-04 1983-05-04 Procedimiento para la obtencion de lineas de celulas animales y humanas cultivables permanentemente.

Country Status (18)

Country Link
US (1) US5114847A (es)
EP (1) EP0093436B1 (es)
JP (1) JPH0753110B2 (es)
AU (1) AU538828B2 (es)
CA (1) CA1201396A (es)
DD (1) DD210708A5 (es)
DE (2) DE3245665A1 (es)
DK (1) DK199083A (es)
ES (1) ES8402346A1 (es)
FI (1) FI85282C (es)
GR (1) GR78532B (es)
HU (1) HU196456B (es)
IE (1) IE54881B1 (es)
IL (1) IL68515A (es)
LV (1) LV11042B (es)
PT (1) PT76629B (es)
SU (1) SU1424744A3 (es)
YU (1) YU94883A (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1214123A (en) * 1983-01-20 1986-11-18 Masashi Matsui Cell lines for use in the preparation of hybridoma cells
DE3342736A1 (de) * 1983-11-25 1985-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Hybridoma-antikoerper
FR2565995B1 (fr) * 1984-03-07 1987-10-23 Centre Nat Rech Scient Cellules hybrides productrices d'un polypeptide determine et obtenu a partir de cellules primaires naturellement capables d'exprimer ce polypeptide ou un polypeptide equivalent, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production dudit polypeptide
DE3420926A1 (de) * 1984-06-05 1985-12-05 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagenz zur differenzierten bestimmung von isoenzymen der alkalischen phosphatase sowie hierzu geeigneter monoklonaler antikoerper
FR2581393B2 (fr) * 1985-05-02 1989-07-21 Grp Genie Genetique Cellules hybrides productrices d'un antigene caracteristique du virus de l'hepatite b obtenu a partir d'hepatocytes et de cellules etablies de singe, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production de l'antigene susdit
EP0225916A1 (en) * 1985-06-11 1987-06-24 The Upjohn Company Transfer of male sterility in carrots
DE3525926A1 (de) 1985-07-19 1987-01-29 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung von pankreas-alpha-amylase
EP0239102A3 (en) * 1986-03-28 1989-07-12 Tsuji, Kimiyoshi Process for the formation of human-human hybridoma
DE3627326A1 (de) * 1986-08-12 1988-02-18 Boehringer Mannheim Gmbh Immortalisierung durch dns-uebertragung
US5001065A (en) * 1987-05-27 1991-03-19 Cetus Corporation Human cell line and triomas, antibodies, and transformants derived therefrom
US5175004A (en) * 1988-12-27 1992-12-29 Matsumura Kenneth N Propagatable, new combinant cells for cellular replacement therapy
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5358844A (en) * 1993-02-18 1994-10-25 Brigham And Women's Hospital, Inc. Preservation of blood platelets
JP3096737B1 (ja) * 1999-07-19 2000-10-10 工業技術院長 ヒト・動物細胞培養液
WO2023069575A1 (en) * 2021-10-21 2023-04-27 Parow Entheobiosciences Llc Method for producing 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) in vitro

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1594097A (en) * 1976-12-16 1981-07-30 Int Inst Of Differentiation Production of specific immune nucleic acids cell dialysates and antibodies
US4394448A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
JPS5852634B2 (ja) * 1980-12-05 1983-11-24 株式会社林原生物化学研究所 ウロキナ−ゼの製造法
ZA824218B (en) * 1981-06-29 1983-04-27 Cetus Corp Plasmid for producing human insulin
US4465769A (en) * 1981-12-11 1984-08-14 The United States Of America As Represented By The Department Of Health And Human Services Non-transformed thymidine kinaseless cell line and its use for testing tumorigenic potential of genes
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes

Also Published As

Publication number Publication date
EP0093436A2 (de) 1983-11-09
CA1201396A (en) 1986-03-04
DK199083D0 (da) 1983-05-04
PT76629A (de) 1983-06-01
GR78532B (es) 1984-09-27
YU94883A (en) 1988-10-31
JPH0753110B2 (ja) 1995-06-07
FI831509L (fi) 1983-11-05
LV11042B (en) 1996-06-20
DK199083A (da) 1983-11-05
EP0093436B1 (de) 1986-11-05
DD210708A5 (de) 1984-06-20
DE3367412D1 (en) 1986-12-11
US5114847A (en) 1992-05-19
IE830945L (en) 1983-11-04
IL68515A0 (en) 1983-07-31
IE54881B1 (en) 1990-03-14
IL68515A (en) 1988-11-15
FI85282C (fi) 1992-03-25
AU538828B2 (en) 1984-08-30
SU1424744A3 (ru) 1988-09-15
JPS61205486A (ja) 1986-09-11
FI831509A0 (fi) 1983-05-03
FI85282B (fi) 1991-12-13
PT76629B (de) 1985-12-03
EP0093436A3 (en) 1984-05-02
ES8402346A1 (es) 1984-02-01
AU1414183A (en) 1983-11-10
DE3245665A1 (de) 1983-11-10
HU196456B (en) 1988-11-28
LV11042A (lv) 1996-02-20

Similar Documents

Publication Publication Date Title
ES522086A0 (es) Procedimiento para la obtencion de lineas de celulas animales y humanas cultivables permanentemente.
ES521333A0 (es) Procedimiento y aparato para la recoleccion de maiz u otros frutos de grano.
MX7372A (es) Drivados de tetrahidronaftalina e indano y procedimiento para su preparacion.
ES519559A0 (es) Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas.
BR8208082A (pt) Copolimeros hidrossoluveis, sua obtencao e sua aplicacao
ES2023385B3 (es) Elastomeros de poliuretano lineales y procedimiento para su obtencion.
ES505616A0 (es) Procedimiento para la obtencion de uretanos n,o-disustitui- dos
ES522698A0 (es) Procedimiento para la obtencion de abonos minerales de efecto prolongado y homogenico.
ES525098A0 (es) Procedimiento para la obtencion de cuerpos moldeados
IT1084232B (it) Paglia artificiale in particolare per lettiere, e procedimento e apparecchiatura per la sua fabbricazione.
ES525682A0 (es) Procedimiento y dispositivo para la fabricacion de elementos de confiteria, especialmente de barquillo
MX156530A (es) Procedimiento mejorado para la obtencion de carboximetilcelulosa
IT8123056A0 (it) Preparato cosmetico e procedimento per la sua preparazione.
DK150583D0 (da) Fremgangsmade til foroegelse af droevtyggende dyrs fermentering i vommen og foder til udfoerelse af fremgangsmaden
MX5719A (es) N-fenilsulfonil-n'-pirimidinil y -triazinil-ureas y procedimiento para su preparacion.
IT1141039B (it) Formulazioni biodegradabili che favoriscono la crescita e procedimento di trattamento
ES514698A0 (es) Procedimiento para la obtencion de uretanos.
FR2524304B1 (fr) Peau artificielle
DK453483A (da) Koncentrerede vegetabilske og animalske cremer
ES499416A0 (es) Procedimiento para la obtencion de esteres de trifluormetil-bencilo de efecto pesticida
ES528265A0 (es) Procedimiento para la obtencion de cuerpos moldeados
BR8302616A (pt) Dispositivo para implante de cabelo
IT1165580B (it) N.s-diacetilcisteina e procedimento per la sua preparazione
ES500787A0 (es) Procedimiento y aparato para la fabricacion de enlaza per- chada.
MX159589A (es) Procedimiento para la obtencion de amoniaco